Immatics (IMTX) Capital Expenditures (2019 - 2025)

Immatics recorded quarterly Capital Expenditures of -$1.1 million in Q4 2025, up 10.98% quarter-over-quarter from -$1.3 million in Q3 2025, and up 36.88% year-over-year from -$824903.9 in Q4 2024.

Immatics' Capital Expenditures history runs 7 years deep, the most recent figure standing at -$1.1 million for Q4 2025.

  • In Q4 2025, Capital Expenditures rose 36.88% year-over-year to -$1.1 million; the TTM figure through Dec 2025 stood at -$7.2 million (up 58.95% YoY), while the FY2025 annual figure was -$7.4 million, up 57.39% from the prior year.
  • Capital Expenditures came in at -$1.1 million for Q4 2025 at Immatics, up from -$1.3 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $56.3 million in Q4 2023 to a low of -$11.6 million in Q2 2023.
  • A 5-year average of $386663.4 and a median of -$1.6 million in 2025 frame the typical range for Capital Expenditures.
  • Across the five-year window, Capital Expenditures surged 545.09% in 2022 and sank 1248.09% in 2023, its largest moves.
  • Immatics' Capital Expenditures stood at -$2.1 million in 2021, then soared by 545.09% to $9.3 million in 2022, then jumped by 504.3% to $56.3 million in 2023, then sank by 103.18% to -$1.8 million in 2024, then surged by 36.88% to -$1.1 million in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods registered -$1.1 million, -$1.3 million, and -$1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 133.40 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 230.60 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 21.83 Mn
10 Immatics 1.80 Bn 1.80 Bn - -1.13 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -1.13 Mn
Dec 31, 2025 -1.13 Mn
Sep 30, 2025 -1.27 Mn
Sep 30, 2025 -1.27 Mn
Jun 30, 2025 -1.62 Mn
Jun 30, 2025 -1.62 Mn
Mar 31, 2025 -3.23 Mn
Mar 31, 2025 -3.23 Mn
Dec 31, 2024 -1.79 Mn
Dec 31, 2024 -1.79 Mn
Sep 30, 2024 -3.08 Mn
Sep 30, 2024 -3.08 Mn
Jun 30, 2024 -2.82 Mn
Jun 30, 2024 -2.82 Mn
Mar 31, 2024 -9.97 Mn
Mar 31, 2024 -9.97 Mn
Dec 31, 2023 56.28 Mn
Dec 31, 2023 56.28 Mn
Sep 30, 2023 -7.08 Mn
Sep 30, 2023 -7.08 Mn
Jun 30, 2023 -11.64 Mn
Jun 30, 2023 -11.64 Mn
Mar 31, 2023 -4.63 Mn
Mar 31, 2023 -4.63 Mn
Dec 31, 2022 9.31 Mn
Dec 31, 2022 9.31 Mn
Sep 30, 2022 -1.44 Mn
Sep 30, 2022 -1.44 Mn
Jun 30, 2022 -863,248.86
Jun 30, 2022 -863,248.86
Mar 31, 2022 -1.30 Mn
Mar 31, 2022 -1.30 Mn
Dec 31, 2021 -2.09 Mn
Dec 31, 2021 -2.09 Mn
Sep 30, 2021 -1.61 Mn
Sep 30, 2021 -1.61 Mn
Jun 30, 2021 -1.62 Mn
Jun 30, 2021 -1.62 Mn
Mar 31, 2021 -681,523.40
Mar 31, 2021 -681,523.40
Dec 31, 2020 15.84 Mn
Dec 31, 2020 15.84 Mn
Sep 30, 2020 -1.58 Mn
Sep 30, 2020 -1.58 Mn
Jun 30, 2020 -2.35 Mn
Jun 30, 2020 -2.35 Mn
Mar 31, 2020 -2.63 Mn
Mar 31, 2020 -2.63 Mn
Dec 31, 2019 -819,096.88
Dec 31, 2019 -819,096.88
Sep 30, 2019 -278,182.51
Sep 30, 2019 -278,182.51